Access to GLP-1 Weight Loss Drugs in the US, Canada, Switzerland, and Germany.
Sign Up to like & getrecommendations! Published in 2024 at "JAMA internal medicine"
DOI: 10.1001/jamainternmed.2024.2559
Abstract: This Viewpoint compares use and costs of glucagon-like peptide 1 (GLP-1) receptor agonists for weight loss between the US and 3 other peer countries. read more here.
Keywords: glp; weight loss; loss drugs; access glp ... See more keywords